@article{oai:dmu.repo.nii.ac.jp:00000918,
 author = {Masuda, Akinori and Abe, Hideyuki and Mizuno, Tomoya and Furuya, Nobutaka and Kambara, Tsunehito and Nakanishi, Kimihiro and Kamai, Takao and Fukabori, Yoshitatsu and Honda, Mikihiko and Yamanishi, Tomonori and Yoshida, Ken-ichiro},
 issue = {1},
 journal = {Dokkyo journal of medical sciences},
 month = {Mar},
 note = {SUMMARYAbout one half of all advanced germ cell tumor( GCT) patients with poor prognosis defined by the InternationalGerm Cell Cancer Collaborative Group (IGCCCG) die of cancer. We evaluated salvage high-dosechemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSCT) for patients with poorprognosis advanced GCT in Dokkyo Medical University. Three patients with poor prognosis advanced GCTwere treated with HDCT as salvage chemotherapy. Two patients had primary testicular GCT and one patienthad primary mediastinal GCT. Treatment responses were pathological complete remission( CR) in one,surgical CR in one and partial remission (PR) in one. Effectiveness and side effects of HDCT with PBSCTfor poor prognosis cases with advanced GCT were shown in this study. However, further accumulation ofthese studies is needed., 原著, Original},
 pages = {17--23},
 title = {High-dose Chemotherapy with Peripheral Blood Stem Cell Transplantation for Patients with Poor PrognosisAdvanced Germ Cell Tumor},
 volume = {38},
 year = {2011}
}